Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Nov. 30, 2024	Dec. 02, 2023	Nov. 30, 2024	Dec. 02, 2023
Operating activities:
Net loss	$ (751)	$ (1,797)	$ (161)	$ (570)
Adjustments to reconcile net loss to cash provided by operating activities:
Unrealized foreign currency loss (gain)	141	(268)	(241)	(305)
Depreciation and amortization	1,015	1,116	2,059	2,114
Inventory provisions	84	192	223	277
Share-based compensation expense	313	283	906	766
(Gain) loss on disposal of assets	(2)	70	(4)	70
Deferred income taxes	(21)	51	(79)	46
Change in assets and liabilities:
Accounts receivable	4,721	1,790	(1,137)	6,252
Inventories	(1,617)	(3,069)	(1,741)	(6,220)
Prepaid expenses and other assets	67	(618)	38	(209)
Accounts payable	500	1,233	4,664	(1,132)
Accrued liabilities	641	1,502	546	378
Other	374	315	804	348
Net cash provided by operating activities	5,465	800	5,877	1,815
Investing activities:
Capital expenditures	(517)	(1,515)	(1,443)	(2,656)
Proceeds from sale of property, plant & equipment	0	0	7	0
Net cash used in investing activities	(517)	(1,515)	(1,436)	(2,656)
Financing activities:
Proceeds from issuance of common stock	163	15	307	342
Cash dividends paid on common and Class B common stock	(853)	(845)	(1,703)	(1,688)
Proceeds from revolving credit facility	0	0	1,000	0
Repayment of revolving credit facility	0	0	(1,000)	0
Other	3	0	(159)	(119)
Net cash used in financing activities	(687)	(830)	(1,555)	(1,465)
Effect of exchange rate changes on cash and cash equivalents	(661)	190	(514)	94
Increase (decrease) in cash and cash equivalents	3,600	(1,355)	2,372	(2,212)
Cash and cash equivalents at beginning of period	23,035	24,124	24,263	24,981
Cash and cash equivalents at end of period	$ 26,635	$ 22,769	$ 26,635	$ 22,769